A Full-Service, Global Clinical Research Organization (CRO)
Health Decisions is a privately held global CRO with more than 20 years of experience providing adaptive consulting, study management and technology - enabling drug, biotech and medical device companies to achieve their development goals, faster. Health Decisions has conducted successful Phase I - IV trials, global registration studies and multiple 510(k)s and PMAs worldwide in all major therapeutic areas.
Consulting
Health Decisions works with sponsors to customize a consulting program that leverages the appropriate adaptive techniques specific to each study – from small trials to large multinational programs for drugs, biologics and medical devices. As the first CRO to receive FDA approval for an adaptive study in oncology, Health Decisions has the experience sponsors need to successfully design and execute adaptive studies.
Clinical Research Services
Through Agile Clinical Development—a strategic three-pronged approach that combines adaptive design, adaptive operations and proprietary technology—Health Decisions' full-service trial management team shortens timelines and reduces risks in drug development.
Medical Device Research Services
Regulations are tightening, and it is becoming increasingly important for medical device companies to partner with a strategic development organization that understands the device industry and has extensive medical device trial expertise.
Technology
Unlike traditional webEDC and CTMS systems, Health Decisions’ HD360° Clinical Management System combines flexible data capture and powerful data management with advanced reporting, collaboration and sophisticated business intelligence.